Screening and Treatment System for Opiate Dependence

(C-DOSETaP Trial)

This trial tests a new system called C-DOSETaP to assist individuals with opioid use disorder (OUD). The researchers aim to determine if the system can enhance OUD screening, improve ongoing health care, increase the use of medications for OUD treatment, and reduce opioid-related deaths in the community. Suitable participants have OUD and receive care at the University of Illinois Hospital and Clinics. As an unphased trial, this study offers participants the chance to contribute to innovative research that could significantly improve OUD treatment and outcomes.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that the C-DOSETaP System is a new method designed to improve care for people with opioid use disorder (OUD). It enhances screening and treatment by using computerized checks and patient-reported information. As this system is not a medication or direct medical treatment, typical safety concerns like side effects do not apply. Although specific safety data for this system is unavailable, its focus on improving patient care and involvement suggests a low risk of harm. The system aims to connect more patients with proven medications for OUD, such as methadone, buprenorphine, and naltrexone, which are known to be safe. Overall, the C-DOSETaP System is expected to be well-received as it primarily enhances existing care processes.¹²³⁴⁵

Researchers are excited about the C-DOSETaP System because it offers a new way to identify and manage opioid use disorder (OUD), which is different from traditional treatments like methadone or buprenorphine. This system integrates advanced screening with personalized treatment options, potentially allowing for more precise and timely interventions. By focusing on early detection and tailored care, C-DOSETaP aims to improve outcomes for individuals struggling with OUD, addressing a critical need in managing this challenging condition.

Studies have shown that effective treatment plans for opioid use disorder (OUD) can lower overdose rates and reduce emergency care needs. Research indicates that only a small number of people needing treatment for OUD receive the recommended medications, which are essential for effective management. This trial will evaluate the C-DOSETaP System, designed to improve treatment results by encouraging medication use and ensuring continuous care. Additionally, long-term studies suggest that structured treatment plans can lead to better outcomes over time, such as fewer opioid-related deaths. These findings highlight the potential benefits of comprehensive systems in treating OUD effectively.²⁴⁶⁷⁸